“MCC950, an NLRP3 Inflammasome Inhibitor, Shows Renoprotective Effects in Chronic Renal Failure Rat Model”

https://pubmed.ncbi.nlm.nih.gov/38114914

The NLRP3 inflammasome inhibitor MCC950 shows promise as a renopreventive treatment for chronic renal failure (CRF) in rats, as demonstrated by improved blood pressure, urine and serum markers, and reduced renal tissue damage.